What are the biggest marketing fines in regulated markets?

Among the best known are JUUL's $462 million multi-state settlement over youth-targeted vape marketing, Teami's $15.2 million FTC judgment over fake health claims and undisclosed influencer posts, Health Formulas' roughly $9.2 million forfeiture over unproven supplement claims, and GoodRx's $1.5 million FTC penalty for leaking health data to ad platforms. Curaleaf took no fine at all, yet lost hundreds of millions in market value in one day after an FDA warning letter.

Can a brand be punished for influencer posts that are not labeled as ads?

Yes. Teami was charged by the FTC in part because it paid Cardi B and Jordin Sparks to promote its teas on Instagram without clearly disclosing the posts were paid ads. The FTC also sent warning letters to all ten of the influencers personally, so both the brand and the creators carry the risk.

Do health data privacy mistakes count as marketing violations?

They do. GoodRx paid a $1.5 million FTC penalty for feeding customers' prescription names and health conditions to Facebook and Google through advertising tracking pixels. BetterHelp paid $7.8 million and Cerebral about $7 million for the same mistake, so telehealth privacy is a repeat enforcement target.

Can a brand lose money from a regulator warning even without a fine?

Yes. The FDA never charged Curaleaf a cent. The public warning letter alone, over claims that CBD treats cancer, Alzheimer's, and opioid withdrawal, dropped the stock about 7% in a single day, erased hundreds of millions in market value, and brought a shareholder lawsuit.

Back to home

regulated markets · marketing fines

Five Regulated Brands Fined for Obvious Marketing Mistakes

Five regulated brands, five avoidable marketing mistakes. Curaleaf, Health Formulas, GoodRx, Teami, and JUUL, what each one did and what it cost them.

By Dennis Ksendzov, Founder, Influencer AdvisoryJuly 8, 20265 min read

Key takeaways

Curaleaf drew a public FDA warning for claiming CBD treats cancer and Alzheimer's, and its stock fell about 7% in one day.
Health Formulas forfeited about $9.2 million, plus a Ferrari, over unproven sexual-performance claims and unauthorized recurring charges.
GoodRx paid a first-of-its-kind $1.5 million FTC penalty for feeding prescription data to Facebook and Google ad pixels.
Teami faced a $15.2 million FTC judgment over fake health claims and undisclosed Cardi B and Jordin Sparks posts.
JUUL's youth-marketing settlements passed $1 billion, and it is now banned from paying social media influencers at all.

Regulated markets · Marketing fines

Every brand below sells the kind of regulated product you sell, cannabis, sexual and hormonal health, telehealth, supplements, or age-gated goods. None of these penalties came from a regulator finding a clever loophole. They came from obvious mistakes in the marketing itself: claims with no proof, paid posts with no disclosure, customer data handed to ad platforms, and age-gated products dressed up for kids.

Here are five, one from each corner of the market we work in.

1. Cannabis & CBD - Curaleaf

FDA warning letter · 2019 · CBD

One of the biggest cannabis companies in the country drew a public FDA warning for selling CBD products with claims they treat cancer, Alzheimer's, and opioid withdrawal, claims it had no science for, and its stock fell about 7% in a single day (as much as 14% intraday), erasing hundreds of millions in market value and drawing a shareholder lawsuit, without the FDA charging a cent.

Source: FDA warning letter (fda.gov)

2. Sexual & hormonal health - Health Formulas

FTC court action · 2016 · male-enhancement supplements

The marketers of a line of male-enhancement supplements forfeited about $9.2 million in assets, and literally handed over a Ferrari, to settle FTC charges for unproven sexual-performance claims and quietly enrolling buyers in recurring charges they never agreed to.

Source: FTC press release (ftc.gov)

3. Telehealth & online pharmacy - GoodRx

FTC penalty · 2023 · online pharmacy

GoodRx paid a $1.5 million FTC penalty, the first ever of its kind, for quietly feeding customers' prescription names and health conditions to Facebook and Google through advertising tracking pixels, after telling users their health data was safe.

Source: FTC press release (ftc.gov)

4. Supplements & nootropics - Teami

FTC judgment · 2020 · detox tea

Detox-tea brand Teami faced a $15.2 million FTC judgment (settled for the $1 million it could pay) for claiming its teas fight cancer and cause rapid weight loss, and for paying Cardi B and Jordin Sparks to promote it on Instagram without clearly disclosing the posts were paid ads.

Source: FTC press release (ftc.gov)

5. Age-gated / vape - JUUL

Multi-state settlement · 2023 · nicotine vape

JUUL agreed to a $462 million multi-state settlement, one of several deals that have pushed its youth-marketing payouts past $1 billion, for selling addictive nicotine with sweet flavors, young models, and youth-friendly social media, and the settlements now ban it from ever paying social-media influencers again.

Source: New York Attorney General (ag.ny.gov)

It's a pattern, not five flukes

Telehealth privacy is a repeat target. BetterHelp paid $7.8 million and Cerebral about $7 million for the exact same mistake GoodRx made, leaking customer health data to ad platforms.
CBD claims drew a whole FTC sweep. "Operation CBDeception" hit a string of sellers, so Curaleaf was far from alone.
Undisclosed paid posts are a named FTC priority. In the Teami case the FTC also sent warning letters to all ten of the influencers personally.

Every one of these mistakes is the kind of thing a script review, a disclosure check, or a tracking audit catches before it ships. That review layer is exactly what we build into every campaign for regulated brands.

The offer

An influencer program run by people who already know these rules costs less than a single one of these fines. That is the job: we keep your claims provable, your disclosures clean, your customer data out of the wrong hands, and your brand away from the audiences you are not allowed to reach.

Talk with us about your program

Sources are official FTC, FDA, and state Attorney General releases, plus major outlets (CNBC, Boston Globe, Law360) for the market-value figures. This is research, not legal advice. Figures were verified against primary sources on June 9, 2026. Open each link to re-confirm.

Frequently asked

What are the biggest marketing fines in regulated markets?
Among the best known are JUUL's $462 million multi-state settlement over youth-targeted vape marketing, Teami's $15.2 million FTC judgment over fake health claims and undisclosed influencer posts, Health Formulas' roughly $9.2 million forfeiture over unproven supplement claims, and GoodRx's $1.5 million FTC penalty for leaking health data to ad platforms. Curaleaf took no fine at all, yet lost hundreds of millions in market value in one day after an FDA warning letter.
Can a brand be punished for influencer posts that are not labeled as ads?
Yes. Teami was charged by the FTC in part because it paid Cardi B and Jordin Sparks to promote its teas on Instagram without clearly disclosing the posts were paid ads. The FTC also sent warning letters to all ten of the influencers personally, so both the brand and the creators carry the risk.
Do health data privacy mistakes count as marketing violations?
They do. GoodRx paid a $1.5 million FTC penalty for feeding customers' prescription names and health conditions to Facebook and Google through advertising tracking pixels. BetterHelp paid $7.8 million and Cerebral about $7 million for the same mistake, so telehealth privacy is a repeat enforcement target.
Can a brand lose money from a regulator warning even without a fine?
Yes. The FDA never charged Curaleaf a cent. The public warning letter alone, over claims that CBD treats cancer, Alzheimer's, and opioid withdrawal, dropped the stock about 7% in a single day, erased hundreds of millions in market value, and brought a shareholder lawsuit.